Detalhe da pesquisa
1.
Ethnic diversity in treatment response for colorectal cancer: proof of concept for radiomics-driven enrichment trials.
Eur Radiol
; 33(12): 9254-9261, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37368111
2.
Evaluation of publicly available in vitro drug sensitivity models for ovarian and uterine cancer.
Gynecol Oncol
; 160(1): 295-301, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33190933
3.
Comparing RECIST 1.1 and iRECIST in advanced melanoma patients treated with pembrolizumab in a phase II clinical trial.
Eur Radiol
; 31(4): 1853-1862, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32995974
4.
Clinical pharmacodynamic/exposure characterisation of the multikinase inhibitor ilorasertib (ABT-348) in a phase 1 dose-escalation trial.
Br J Cancer
; 118(8): 1042-1050, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29551775
5.
Model-based approach to identify predictors of paclitaxel-induced myelosuppression in "real-world" administration.
CPT Pharmacometrics Syst Pharmacol
; 12(7): 929-940, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37101403
6.
An imaging signature to predict outcome in metastatic colorectal cancer using routine computed tomography scans.
Eur J Cancer
; 161: 138-147, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34916122
7.
Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging Analysis.
JAMA Oncol
; 8(3): 385-392, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35050320
8.
Enhanced Detection of Treatment Effects on Metastatic Colorectal Cancer with Volumetric CT Measurements for Tumor Burden Growth Rate Evaluation.
Clin Cancer Res
; 26(24): 6464-6474, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32988968
9.
Comparison of tumor size assessments in tumor growth inhibition-overall survival models with second-line colorectal cancer data from the VELOUR study.
Cancer Chemother Pharmacol
; 82(1): 49-54, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29700575
10.
Vol-PACT: A Foundation for the NIH Public-Private Partnership That Supports Sharing of Clinical Trial Data for the Development of Improved Imaging Biomarkers in Oncology.
JCO Clin Cancer Inform
; 2: 1-12, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30652552
11.
Get Real: Integration of Real-World Data to Improve Patient Care.
Clin Pharmacol Ther
; 107(4): 722-725, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32142592
12.
Predicting Response to Histone Deacetylase Inhibitors Using High-Throughput Genomics.
J Natl Cancer Inst
; 107(11)2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26296641
13.
Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide.
Clin Cancer Res
; 21(22): 5092-9, 2015 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26199386
14.
Technical considerations in the development of circulating peptides as pharmacodynamic biomarkers for angiogenesis inhibitors.
J Clin Pharmacol
; 54(6): 682-7, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24374901